Kristen Whitaker MD, MS

Kristen Whitaker, MD, MS is a board-certified medical oncologist at MedStar Washington Hospital Center. Prior to joining MedStar Washington Hospital Center, Dr. Whitaker served as an assistant professor at the NCI Comprehensive Cancer Center, Fox Chase, in Philadelphia, PA for four years, where she treated patients with breast cancer and patients at high risk for developing breast and other types of cancers.

Dr. Whitaker specializes in treating patients with breast cancer. She is a member of the multidisciplinary team that makes up the Breast Health Program at MedStar Washington Hospital Center. Dr. Whitaker’s approach to patient care is centered around collaboration with other providers and patients and providing evidence-based recommendations for patient care. She strives to take the unique needs of each of her patients into consideration and incorporates newer tools, such as genetic testing and tumor molecular profiling, to tailor treatments for her patients. Her goal is to ensure that her patients have the best possible outcomes from their cancer while taking care to minimize the number of therapies, side effects of therapy and personal hardships that patients experience because of their cancer treatment.

When Dr. Whitaker meets with patients, she is optimistic and positive because she knows that there are many effective therapy options available that can treat and, in many cases, cure her patients. While chemotherapy and hormonal therapy were once the cornerstone of breast cancer treatment, today Dr. Whitaker is excited to offer her patients newer therapies, such as targeted therapies and immunotherapy, which improve cancer outcomes with less side effects. She is particularly excited that MedStar Washington Hospital Center has many clinical trial options, allowing patients from diverse backgrounds earlier access to what may become the breast cancer treatments of the future.

Dr. Whitaker is passionate about working towards eliminating racial health disparities, especially among patients with cancer. To that end, she has been published and has received multiple awards, including the 2022 NIH Loan Repayment Health Disparities Award and a 2022 AACR Career Development Award to Further Diversity, Equity, and Inclusion in Clinical Cancer Research.

Dr. Whitaker received her medical degree from Drexel University College of Medicine in Philadelphia, PA. She then completed a three-year residency in internal medicine at George Washington University, prior to completing a three-year fellowship in hematology/oncology at the NCI Comprehensive Cancer Center, The University of Chicago. She simultaneously completed a Master of Science at the University of Chicago while completing her fellowship. She is a member of the American Society of Clinical Oncology and the American Association for Cancer Research.